Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, Jul 1997, 469-473, Vol 4, No. 4
T Lazzarotto, P Spezzacatena, P Pradelli, DA Abate, S Varani and MP Landini
Diagnosis of primary human cytomegalovirus (HCMV) infection is accomplished
exclusively by serologic testing. Among the possible methods, the
determination of immunoglobulin G (IgG) avidity is one of the least
explored. In this work, we used a commercially available kit to test
anti-HCMV IgG avidity in 336 serum samples from pregnant women and
transplant recipients undergoing virologically proven HCMV primary or
nonprimary infections and from latently infected blood donors. Our results
demonstrate that the anti-HCMV IgG avidity test differentiates primary from
nonprimary HCMV infections in both pregnant women and solid organ
transplant recipients. In fact, 88.6% of primary infections and no
secondary infections showed low-avidity IgG to HCMV. In particular, low IgG
avidity is a marker of primary infection for 18 to 20 weeks after onset of
symptoms in both immunocompromised and immunocompetent subjects.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects
Department of Clinical and Experimental Medicine, University of Bologna, Italy.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |